Tag: growth pharma

November 25, 2018

What is In-licensing?

In-licensing may be pharma’s preferred mode of business development these days. Should that impact your investment strategy?
March 27, 2017

Allergan and Paratek Show Positive Results For Acne Treatment

Allergan (NYSE:AGN) and Paratek Pharmaceuticals (NASDAQ:PRTK) announced successful initial results for the two and Phase 3 trials of their acne...
December 26, 2016

Top Pharmaceutical News Stories of 2016

2016 saw countless pharmaceutical companies taken to task for price gouging. Close to the end of the year, a related...
December 20, 2016

Allergan to Acquire Acelity L.P. Inc.'s LifeCell Corporation for $2.9 Billion

Allergan, a leading global biopharmaceutical company, and Acelity today announced that they have entered into a definitive agreement under which...
November 16, 2016

Allergan Announces Partnership with Amy Dixon, Elite Paratriathlete

Allergan today announced a national partnership with Amy Dixon, world champion paratriathlete and irritable bowel syndrome with diarrhea (IBS-D) patient.
October 4, 2016

Another Acquisition for Allergan Makes Six Since August

Six acquisitions indicate Allergan’s refined strategic focus, as well as CEO Brent Saunders’ continued commitment to a “growth pharma” business...
October 3, 2016

Allergan Enters Into Licensing Agreement with AstraZeneca to Obtain Worldwide Rights to Inflammatory Disorder Development Program

Under the terms of the agreement, Allergan will make an upfront payment to AstraZeneca of $250 million for the exclusive,...